Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
7,837.40
-100.10
(-1.26%)
ASX 200
7,575.90
-107.10
(-1.39%)
AUD/USD
0.6547
+0.0024
(+0.37%)
OIL
83.71
+0.14
(+0.17%)
GOLD
2,359.60
+17.10
(+0.73%)
Bitcoin AUD
98,307.22
+642.29
(+0.66%)
IGC Pharma, Inc. (IGC)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.4300
-0.0090
(-2.05%)
At close: 04:00PM EDT
0.4347
+0.00
(+1.09%)
After hours:
07:59PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
1,343
911
397
898
Cost of revenue
749
469
203
785
Gross profit
594
442
194
113
Operating expenses
Research development
3,314
3,461
2,330
929
Selling general and administrative
8,191
8,552
13,292
7,908
Total operating expenses
11,505
12,013
15,622
8,837
Operating income or loss
-10,911
-11,571
-15,428
-8,724
Total other income/expenses net
106
65
412
-87
Income before tax
-10,805
-11,506
-15,016
-8,811
Income tax expense
0
0
0
0
Income from continuing operations
-10,805
-11,506
-15,016
-8,811
Net income
-10,805
-11,506
-15,016
-8,811
Net income available to common shareholders
-10,805
-11,506
-15,016
-8,811
Basic EPS
-0.20
-0.22
-0.30
-0.21
Diluted EPS
-0.20
-0.22
-0.30
-0.21
Basic average shares
53,383
52,576
49,992
41,963
Diluted average shares
53,383
52,576
49,992
41,963
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.